Form 8-K - Current report:
SEC Accession No. 0001193125-25-039225
Filing Date
2025-02-27
Accepted
2025-02-27 16:09:05
Documents
14
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d829130d8k.htm   iXBRL 8-K 25817
2 EX-99.1 d829130dex991.htm EX-99.1 146683
  Complete submission text file 0001193125-25-039225.txt   306943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20250227.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20250227_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20250227_pre.xml EX-101.PRE 10806
16 EXTRACTED XBRL INSTANCE DOCUMENT d829130d8k_htm.xml XML 3505
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 25678768
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)